81_FR_37729 81 FR 37617 - National Cancer Institute; Notice of Closed Meetings

81 FR 37617 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 112 (June 10, 2016)

Page Range37617-37618
FR Document2016-13725

Federal Register, Volume 81 Issue 112 (Friday, June 10, 2016) 
[Federal Register Volume 81, Number 112 (Friday, June 10, 2016)]
[Notices]
[Pages 37617-37618]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-13725]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Small-Cell Lung Cancer (SCLC) Consortium: Innovative 
Approaches to the Prevention and Early Detection of Small Cell Lung 
Cancer (U01).
    Date: July 18, 2016.
    Time: 7:30 p.m. to 10:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Timothy C. Meeker, MD, Ph.D., Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W624, Rockville, MD 20892-9750, 240-276-6464, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic 
Development and Mechanisms of Resistance (U01).
    Date: July 19, 2016.
    Time: 8:00 a.m. to 1:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817
    Contact Person: Timothy C. Meeker, MD, Ph.D., Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W624, Rockville, MD 20892-9750, 240-276-6464 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Small-Cell Lung Cancer (SCLC) Consortium: Coordinating Center 
(U24).

[[Page 37618]]

    Date: July 19, 2016.
    Time: 1:30 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Timothy C. Meeker, MD, Ph.D., Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W624, Rockville, MD 20892-9750, 240-276-6464, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Clinical Center Collaborative Research (U01).
    Date: July 22, 2016.
    Time: 9:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 2W914, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Caron A. Lyman, Ph.D., Chief, Scientific Review 
Officer, Research Programs Review, Branch Division of Extramural 
Activities, National Cancer Institute, 9609 Medical Center Drive, 
Room 7W126, Rockville, MD 20892-9750, 240-276-6348, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)


    Dated: June 6, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-13725 Filed 6-9-16; 8:45 am]
BILLING CODE 4140-01-P

Federal Register / Vol. 81, No. 112 / Friday, June 10, 2016 / Notices 37617 members who represent the health involvement in national professional Dated: May 31, 2016. interest of Hispanics/Latinos; Blacks/ organizations. Minh Wendt, African Americans; American Indians Requirements for Nomination Designated Federal Officer, Advisory and Alaska Natives; and/or Asian Submission: Nominations should be Committee on Minority Health. Americans, Native Hawaiians, and other typewritten (one nomination per [FR Doc. 2016–13785 Filed 6–9–16; 8:45 am] Pacific Islanders. nominator). Nomination package should BILLING CODE 4150–29–P There are two impending vacancies include: (1) A letter of nomination that on the ACMH that impact the clearly states the name and affiliation of representation for the health interests of the nominee, the basis for the DEPARTMENT OF HEALTH AND Blacks/African Americans. OMH is nomination (i.e., specific attributes HUMAN SERVICES particularly seeking nominations for which qualify the nominee for service in individuals who can represent the this capacity), and a statement from the National Institutes of Health health interests of this racial and ethnic nominee indicating a willingness to serve as a member of the Committee; (2) National Cancer Institute; Notice of minority group. Nominations that are the nominee’s contact information, Closed Meetings received for individuals to represent other racial and ethnic minority groups including name, mailing address, Pursuant to section 10(d) of the also will be accepted. These telephone number, and email address; Federal Advisory Committee Act, as applications will be retained in files that (3) the nominee’s curriculum vitae amended (5 U.S.C. App.), notice is are maintained by OMH on potential which should not exceed 10 pages; and hereby given of the following meetings. candidates to be considered for the (4) a summary of the nominee’s The meetings will be closed to the ACMH. experience and qualification relative to public in accordance with the Mandatory Professional/Technical the mandatory professional and provisions set forth in sections Qualifications: Nominees must meet all technical criteria listed above. Federal 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., of the following mandatory employees should not be nominated for as amended. The grant applications and qualifications to be eligible for consideration of appointment to this the discussions could disclose consideration: Committee. confidential trade secrets or commercial Individuals selected for appointment property such as patentable material, (1) Expertise in minority health and to the Committee shall be invited to and personal information concerning racial and ethnic health disparities; serve a four-year term. Committee individuals associated with the grant (2) Expertise in developing or members will receive a stipend for applications, the disclosure of which contributing to the development of attending Committee meetings and would constitute a clearly unwarranted science-based or evidence- based health conducting other business in the invasion of personal privacy. policies and/or programs. This expertise interest of the Committee, including per may include experience in the analysis, diem and reimbursement for travel Name of Committee: National Cancer evaluation, and interpretation of expenses incurred. Institute Special Emphasis Panel; Small-Cell federal/state health or regulatory policy; Lung Cancer (SCLC) Consortium: Innovative The Department makes every effort to Approaches to the Prevention and Early (3) Involvement in national, state, ensure that the membership of a HHS regional, tribal, and/or local efforts to Detection of Small Cell Lung Cancer (U01). federal advisory committee is fairly Date: July 18, 2016. improve the health status or outcomes balanced in terms of points of view Time: 7:30 p.m. to 10:00 p.m. among racial and ethnic minority represented and the committee’s Agenda: To review and evaluate grant populations; function. Every effort is made to ensure applications. (4) Educational achievement, that a broad representation of Place: Bethesda Marriott Suites, 6711 professional certification(s) in health- geographic areas, gender, racial and Democracy Boulevard, Bethesda, MD 20817. related fields (e.g., health professions, Contact Person: Timothy C. Meeker, MD, ethnic and minority groups, and the Ph.D., Scientific Review Officer, Resources allied health, behavioral health, public disabled are given consideration for and Training Review Branch, Division of health, health policy, health membership on HHS federal advisory Extramural Activities, National Cancer administration/management, etc.), and committees. Appointment to this Institute, 9609 Medical Center Drive, Room professional experience that will Committee shall be made without 7W624, Rockville, MD 20892–9750, 240– support ability to give expert advice on discrimination because of a person’s 276–6464, meekert@mail.nih.gov. issues related to improving minority race, color, religion, sex (including Name of Committee: National Cancer health and eliminating racial and ethnic pregnancy), national origin, age, Institute Special Emphasis Panel; Small-Cell health disparities; and disability, or genetic information. Lung Cancer (SCLC) Consortium: (5) Expertise in population level Nominations must state that the Therapeutic Development and Mechanisms health data for racial and ethnic of Resistance (U01). nominee is willing to serve as a member minority groups. This expertise may Date: July 19, 2016. of ACMH and appears to have no Time: 8:00 a.m. to 1:30 p.m. include survey, administrative, and/or conflict of interest that would preclude Agenda: To review and evaluate grant clinical data. membership. An ethics review is applications. Desirable Qualifications: conducted for each selected nominee; Place: Bethesda Marriott Suites, 6711 (1) Knowledge and experience in therefore, individuals selected for Democracy Boulevard, Bethesda, MD 20817 health care systems, cultural and nomination will be required to provide Contact Person: Timothy C. Meeker, MD, linguistic competency, social detailed information concerning such Ph.D., Scientific Review Officer, Resources asabaliauskas on DSK3SPTVN1PROD with NOTICES determinants of health, evidence-based matters as financial holdings, and Training Review Branch, Division of Extramural Activities, National Cancer research, data collection (e.g., federal, consultancies, and research grants or Institute, 9609 Medical Center Drive, Room state, tribal, or local data collection), or contracts to permit evaluation of 7W624, Rockville, MD 20892–9750, 240– health promotion and disease possible sources of conflict of interest. 276–6464 meekert@mail.nih.gov. prevention. Individuals selected to serve on the Name of Committee: National Cancer (2) Nationally recognized via peer- ACMH through the nomination process Institute Special Emphasis Panel; Small-Cell reviewed publications, professional will be posted on the OMH Web site Lung Cancer (SCLC) Consortium: awards, advanced credentials, or once selections have been made. Coordinating Center (U24). VerDate Sep<11>2014 19:02 Jun 09, 2016 Jkt 238001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 E:\FR\FM\10JNN1.SGM 10JNN1

37618 Federal Register / Vol. 81, No. 112 / Friday, June 10, 2016 / Notices Date: July 19, 2016. would constitute a clearly unwarranted Place: National Institutes of Health, 6701 Time: 1:30 p.m. to 4:00 p.m. invasion of personal privacy. Rockledge Drive, Bethesda, MD 20892. Agenda: To review and evaluate grant Contact Person: Heidi B Friedman, Ph.D., applications. Name of Committee: Center for Scientific Scientific Review Officer, Center for Place: Bethesda Marriott Suites, 6711 Review Special Emphasis Panel; Member Conflict: Infectious, Reproductive, Asthma Scientific Review, National Institutes of Democracy Boulevard, Bethesda, MD 20817. Health, 6701 Rockledge Drive, Room 1012A, Contact Person: Timothy C. Meeker, MD, and Pulmonary Conditions and Social Sciences and Population Studies. MSC 7770, Bethesda, MD 20892, 301–379– Ph.D., Scientific Review Officer, Resources 5632, hfriedman@csr.nih.gov. and Training Review Branch, Division of Date: July 6, 2016. Time: 1:00 p.m. to 4:00 p.m. Name of Committee: Center for Scientific Extramural Activities, National Cancer Agenda: To review and evaluate grant Review Special Emphasis Panel; PAR–13– Institute, 9609 Medical Center Drive, Room 7W624, Rockville, MD 20892–9750, 240– applications. 375: Nutrigenetics and Nutrigenomics Place:National Institutes of Health, 6701 Approaches for Nutrition Research. 276–6464, meekert@mail.nih.gov. Rockledge Drive, Bethesda, MD 20892 Date: July 12, 2016. Name of Committee: National Cancer (Telephone Conference Call). Time: 8:00 a.m. to 6:00 p.m. Institute Special Emphasis Panel; Clinical Contact Person: Ellen K Schwartz, EDD, Center Collaborative Research (U01). Agenda: To review and evaluate grant Scientific Review Officer, Center for applications. Date: July 22, 2016. Scientific Review, National Institutes of Time: 9:00 a.m. to 2:00 p.m. Place: Residence Inn Bethesda, 7335 Health, 6701 Rockledge Drive, Room 3144, Agenda: To review and evaluate grant Wisconsin Avenue, Bethesda, MD 20814. MSC 7770, Bethesda, MD 20892, 301–828– applications. 6146, schwarel@mail.nih.gov. Contact Person: Gregory S Shelness, Ph.D., Place: National Cancer Institute, Shady Scientific Review Officer, Center for Name of Committee: Center for Scientific Grove, 9609 Medical Center Drive, Room Scientific Review, National Institutes of Review Special Emphasis Panel, Topics in 2W914, Rockville, MD 20850 (Telephone Health, 6701 Rockledge Drive, Room 6156, Microbial Pathogenesis. Conference Call). Date: July 11, 2016. Bethesda, MD 20892–7892, (301) 435–0492, Contact Person: Caron A. Lyman, Ph.D., Time: 8:00 a.m. to 6:00 p.m. shelnessgs@csr.nih.gov. Chief, Scientific Review Officer, Research Agenda: To review and evaluate grant Name of Committee: Center for Scientific Programs Review, Branch Division of applications. Review Special Emphasis Panel; Pediatric Extramural Activities, National Cancer Place: Residence Inn Bethesda, 7335 Diagnostic Biomarkers for Active Pulmonary Institute, 9609 Medical Center Drive, Room Wisconsin Avenue, Bethesda, MD 20814. TB Diseases. 7W126, Rockville, MD 20892–9750, 240– Contact Person: Richard G Kostriken, 276–6348, lymanc@mail.nih.gov. Date: July 12–13, 2016. Ph.D., Scientific Review Officer, Center for Time: 9:00 a.m. to 6:00 p.m. (Catalogue of Federal Domestic Assistance Scientific Review, National Institutes of Agenda: To review and evaluate grant Program Nos. 93.392, Cancer Construction; Health, 6701 Rockledge Drive, Room 3192, applications. 93.393, Cancer Cause and Prevention MSC 7808, Bethesda, MD 20892, 240–519– Research; 93.394, Cancer Detection and Place: National Institutes of Health, 6701 7808, kostrikr@csr.nih.gov. Diagnosis Research; 93.395, Cancer Rockledge Drive, Bethesda, MD 20892 Name of Committee: Center for Scientific (Virtual Meeting). Treatment Research; 93.396, Cancer Biology Review Special Emphasis Panel; PAR14–226: Research; 93.397, Cancer Centers Support; Contact Person: George M Barnas, Ph.D., Limited Competition: National Primate 93.398, Cancer Research Manpower; 93.399, Scientific Review Officer, Center for Research Centers (P51). Cancer Control, National Institutes of Health, Date: July 11–13, 2016. Scientific Review, National Institutes of HHS) Time: 8:00 a.m. to 5:00 p.m. Health, 6701 Rockledge Drive, Room 4220, Agenda: To review and evaluate grant MSC 7818, Bethesda, MD 20892, 301–435– Dated: June 6, 2016. applications. 0696, barnasg@csr.nih.gov. Melanie J. Gray, Place: Silver Cloud Inn—Lake Union, 1150 Name of Committee: Center for Scientific Program Analyst, Office of Federal Advisory Fairview Ave. N., Seattle, WA 98109. Review Special Emphasis Panel; Committee Policy. Contact Person: Maribeth Champoux, Fellowships: Synthetic and Biological [FR Doc. 2016–13725 Filed 6–9–16; 8:45 am] Ph.D., Scientific Review Officer, Center for Chemistry. Scientific Review, National Institutes of Date: July 12–13, 2016. BILLING CODE 4140–01–P Health, 6701 Rockledge Drive, Room 3170, Time: 10:00 a.m. to 6:00 p.m. MSC 7848, Bethesda, MD 20892, 301–594– Agenda: To review and evaluate grant 3163, champoum@csr.nih.gov. DEPARTMENT OF HEALTH AND applications. Name of Committee: Center for Scientific Place: National Institutes of Health, 6701 HUMAN SERVICES Review Special Emphasis Panel; Small Rockledge Drive, Bethesda, MD 20892 Business—Hematology. National Institutes of Health Date: July 11, 2016. (Virtual Meeting). Time: 10:30 a.m. to 5:00 p.m. Contact Person: Charles Selden, Ph.D., Center for Scientific Review; Notice of Agenda: To review and evaluate grant Scientific Review Officer, Center for Closed Meetings applications. Scientific Review, National Institutes of Place: National Institutes of Health, 6701 Health, 6701 Rockledge Drive, Room 5187 Pursuant to section 10(d) of the Rockledge Drive, Bethesda, MD 20892. MSC 7840, Bethesda, MD 20892, 301–451– Federal Advisory Committee Act, as Contact Person: Bukhtiar H Shah, DVM, 3388, seldens@mail.nih.gov. amended (5 U.S.C. App.), notice is Ph.D., Scientific Review Officer, Center for (Catalogue of Federal Domestic Assistance hereby given of the following meetings. Scientific Review, National Institutes of Program Nos. 93.306, Comparative Medicine; The meetings will be closed to the Health, 6701 Rockledge Drive, Room 4120, 93.333, Clinical Research, 93.306, 93.333, public in accordance with the MSC 7802, Bethesda, MD 20892, 301–806– 93.337, 93.393–93.396, 93.837–93.844, provisions set forth in sections, 7314, shahb@csr.nih.gov. asabaliauskas on DSK3SPTVN1PROD with NOTICES 93.846– 93.878, 93.892, 93.893, National 552b(c)(4) and 552b(c)(6), title 5 U.S.C., Name of Committee: Center for Scientific Institutes of Health, HHS) as amended. The grant applications and Review Special Emphasis Panel; RFA–OD– 16–006: Environmental Influences on Child Dated: June 6, 2016. the, discussions could disclose Health Outcomes (ECHO) Coordinating Sylvia L. Neal, confidential trade secrets or commercial Center. property such as patentable, material, Program Analyst, Office of Federal Advisory Date: July 12, 2016. and personal information concerning Committee Policy. Time: 8:00 a.m. to 5:00 p.m. individuals associated with the grant Agenda: To review and evaluate grant [FR Doc. 2016–13724 Filed 6–9–16; 8:45 am] applications, the disclosure of which applications. BILLING CODE 4140–01–P VerDate Sep<11>2014 19:02 Jun 09, 2016 Jkt 238001 PO 00000 Frm 00053 Fmt 4703 Sfmt 9990 E:\FR\FM\10JNN1.SGM 10JNN1


Document Created: 2018-02-08 07:36:03
Document Modified: 2018-02-08 07:36:03
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesJuly 18, 2016.
FR Citation81 FR 37617 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR